Growth Drivers
Growing Cases of Chronic Sinusitis – In the recent period, the cases of chronic sinusitis among the global population have risen considerably owing to the rising air pollution and the presence of toxic pollutants in the air. Therefore, the cases of ear and nasal diseases such as chronic sinusitis have increased considerably across the world. As ear and nasal packing are considered to be an effective solution for otolaryngologists and head and neck surgeons for the treatment of sinusitis, the rise in cases of chronic sinusitis is anticipated to increase the demand for ear and nasal packing in the healthcare industry. As per the data shared by the Centers for Disease Control and Prevention (CDC) in 2019, around 11.6% of Americans and 28.9 million adults in the North American region are diagnosed with sinusitis.
Increase in Level of Air Pollution – Owing to rapid urbanization and industrialization, the level of air pollution has considerably grown up in the past years. As a result, people are now being diagnosed with various kinds of ear and nasal infections and diseases. Therefore, this factor is estimated to generate a high demand for ear and nasal packing for effective treatment. Hence, the increasing air pollution over the world is anticipated to bring lucrative growth opportunities for market growth during the analysis period. The data published by the World Health Organization (WHO) stated that almost 90% of the global population breathes air that exceeds WHO guideline limits and contains high levels of pollutants. Further, it is estimated that air pollution is responsible for taking up almost 11.65% of deaths around the world.
High Focus on Developing the Medical Devices Sector - The data revealed by the India Brand Equity Foundation (IBEF) stated that in FY20, the foreign investments in the Indian medical devices sector increased to USD 301 million from USD 151 million in FY19, which indicates a 98% increment.
Rising Focus on Bringing Advancement in the Healthcare Industry - For instance, investment in medical and health research and development (R&D) in the United States (U.S.) increased by 11% to around USD 245 billion in 2020 from previous years.
Rapid Growth in the Healthcare Industry – According to the latest statistics, it is being calculated that the revenue generated by the global healthcare segment was USD 60 billion in 2023 which is further anticipated to grow further.
Challenges
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
5.5% |
Base Year Market Size (2024) |
USD 244.63 million |
Forecast Year Market Size (2037) |
USD 490.67 million |
Regional Synopsis |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?